行情

PKI

PKI

珀金埃尔默
NYSE

实时行情|Nasdaq Last Sale

94.39
-1.46
-1.52%
盘后: 94.78 +0.39 +0.41% 16:11 12/13 EST
开盘
95.89
昨收
95.85
最高
96.17
最低
94.18
成交量
57.88万
成交额
--
52周最高
103.00
52周最低
71.83
市值
104.87亿
市盈率(TTM)
45.28
分时
5日
1月
3月
1年
5年

分析师评级

14位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

PKI 新闻

  • PerkinElmer Press Release Confirms First FDA-Approved Assay Kit To Screen For DMD In Newborns
  • Benzinga.1天前
  • PerkinElmer Launches First FDA-Approved Assay Kit to Screen for Duchenne Muscular Dystrophy in Newborns
  • Business Wire.1天前
  • UPDATE: 'FDA authorizes first test to aid in newborn screening for Duchenne Muscular Dystrophy' -FDA News Website
  • Benzinga.2天前
  • PerkinElmer Shares Spike To Session High On Volume Amid Report FDA Has Authorized First Test To Aid In Newborn Screening For DMD
  • Benzinga.2天前

更多

所属板块

先进医疗设备和技术
+0.10%
医疗设备和用品
+0.24%

热门股票

名称
价格
涨跌幅

PKI 简况

PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets. It provides analytical instrumentation for the industrial market, which includes the chemical, electronics, energy, lubricant, petrochemical and polymer industries. Its products include AAnalyst, Altus, Aquamatic, Avio, AxION, Clarus, DairyGuard, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, Cell carrier and cell::explorer. The Diagnostics segment is focused on reproductive health, emerging market diagnostics and applied genomics. Its products include AutoDELFIA, BACS-on-Beads, Bioo Scientific, BoBs, Datalytix, Dexela, Dexela CMOS FPDs, Evolution, ViaCord, and Zephyr.
展开

Webull提供PerkinElmer, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。